Takara Bio

Cancer genomics & epigenomics

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur ullamcorper gravida velit, sed imperdiet velit vestibulum et. Cras non sapien sed felis mollis viverra. Donec aliquet tellus sit amet interdum vulputate.

Overview

Cancer genomics & epigenomics

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur ullamcorper gravida libero, in tincidunt magna suscipit a. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Sed non velit at lacus pretium facilisis vel eget urna.

Praesent euismod justo sit amet turpis pulvinar, vel commodo arcu bibendum. Integer nec magna vel elit fermentum condimentum. Takara Bio may support selected workflow stages rather than own every stage of the experiment, so this page describes a sample-led and experiment-led approach before any product is shown.

Workflows & featured products

Explore the workflow first, then review relevant product families

The workflow cards orient researchers by scientific context. Featured products show where Takara Bio may contribute; they are not a substitute for the guided selector below.

Illustrative workflow mapping

Workflow labels and product relationships are shown to validate the page structure. Final terminology, eligibility rules and product mappings must be confirmed with content owners and product managers.

Cancer genomics and epigenomics workflows

Select a workflow to see the products associated with it.

Products for bulk cancer genomics

Related workflow support

Show adjacent products only when they help complete the selected workflow

Related products should be explained by role — quality control, compatibility, indexing or downstream preparation — not shown as generic cross-sell.

Guided product discovery

Research objective to the right workflow

Product names appear only after enough experiment context is available to explain why a result is shown. Every answer stays visible and editable.

Guided product discovery

Research objective to the right workflow

Tell us about your sample and what you plan to measure. We will narrow the workflow before showing relevant products.

We already know this from your journey. You will not be asked to select it again.

Research area:Cancer ResearchResearch focus:Cancer Genomics & Epigenomics
  1. Question 1 of 4

    Starting material

    The sample type determines which recovery and preparation routes are scientifically appropriate.

  2. Question 2 of 4

    Target analyte

    This narrows the workflow to the analyte your experiment depends on.

  3. Question 3 of 4

    Downstream application

    The planned method decides which preparation chemistry is compatible.

  4. Question 4 of 4

    Sample or analysis requirement

    This final constraint decides which workflow variant is the closest match.

Not able to answer?

A scientist can help you choose

Any answers you have already given are carried into the request, so you never repeat yourself.

Expertise, innovation & learning

Cancer genomics & epigenomics resources and insights

Bring the most relevant scientific guidance, education and evidence into the workflow page so researchers can evaluate the approach without leaving the research context.

Infographics

Cancer research workflows at a glance

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur ullamcorper gravida velit, sed imperdiet velit vestibulum et.

View infographics

Webinars & educational videos

Expert perspectives on emerging cancer methods

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur ullamcorper gravida velit, sed imperdiet velit vestibulum et.

Watch webinars & videos

BioView blog

How researchers solve complex cancer questions

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur ullamcorper gravida velit, sed imperdiet velit vestibulum et.

Read customer stories

That's GOOD Science Academy

Learn about our experimental success

Explore foundational training, troubleshooting and scientific learning designed for researchers at every stage.